CNS Pharmaceuticals Inc (CNSP) stock news · rev $27.7K
CNS Pharmaceuticals Inc (CNSP) is a biotechnology company listed on NASDAQ.
This CNSP news page leads with what CNS Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for CNSP yet. We will not pad this page with generic market recap.
Latest reported CNSP revenue for 2023-12-31 was $27.7K. Net income was -$18.9M. CNSP currently screens at market cap $6.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CNSP stock page; for the tape open the quote page.
CNSP stock news FAQ
What are CNSP's latest revenue and net income?
Latest cached CNS Pharmaceuticals Inc (CNSP) revenue for Dec 31, 2023 was $27.7K. Net income was -$18.9M. Statements: https://lician.com/financials/cnsp
What is CNSP's market cap?
CNS Pharmaceuticals Inc (CNSP) market cap is $6.6M on the latest cached fundamentals snapshot.
What kind of company is CNSP?
CNS Pharmaceuticals Inc (CNSP) is a biotechnology company listed on NASDAQ.
Where is CNSP stock news listed?
Cached stock news for CNS Pharmaceuticals Inc (CNSP) is listed at https://lician.com/news/cnsp. Filings: https://lician.com/sec/cnsp
Not investment advice.